脸部注射剂市场规模、份额、成长分析、按产品、按应用、按最终用途、按地区 - 行业预测，2024-2031 年

2022年全球脸部注射剂市场规模为101亿美元，从2023年的113.1亿美元成长到2031年的280.1亿美元，预测期（2024-2031）预计复合年增长率为12.00%。

在脸部美容需求不断增长的推动下，全球脸部注射剂市场将在未来几年显着成长。该领域包括专为美容疗程而设计的注射物质的生产、分销和应用，主要是抗皱、恢復脸部体积和改善整体皮肤外观。这个市场主要围绕着两种主要技术：肉毒桿菌注射和皮肤填充剂，这两种技术都能增加皮肤光泽和水合作用，从而改善质地。随着消费者对脸部化妆品越来越感兴趣，加上年轻人可支配收入迅速增加，美容化妆品支出有望转正。值得注意的是，在消费者对美容趋势的参与推动下，美国脸部注射剂市场预计将在未来的预测期内实现永续的年复合成长率(CAGR)，反映出更广泛的增长趋势。由于社会对外表和自我护理的日益关注，脸部注射剂市场预计将继续扩大，使其成为美容和健康行业投资和创新的关键领域。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价格分析
• 价值链分析
• 市场生态系统
• 贸易分析
• 供应链分析
• 案例研究分析
• 专利分析
• 客户和购买标准分析
• 监管环境
• 创新矩阵
• 主要投资分析
• 关键成功因素
• 竞争程度

脸部注射剂市场：按产品

• 市场概况
• 胶原蛋白和 PMMA 微球
• 透明质酸（HA）
• A型肉毒桿菌毒素
• 烃基磷灰石钙(CaHA)
• 聚左旋乳酸(PLLA)
• 其他的

脸部注射剂市场：依应用分类

• 市场概况
• 脸部线条矫正
• 丰唇术
• 拉皮
• 痤疮疤痕治疗
• 脂肪萎缩的治疗
• 其他的

脸部注射剂市场：依最终用途分类

• 市场概况
• 梅迪斯帕
• 皮肤科诊所
• 医院

脸部注射剂市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Ispen（France）
• Abbvie（US）
• Medytox Inc.（South Korea）
• Merz GmbH and Co. KGaA（Germany）
• Revance Therapeutics, Inc.（US）
• Galderma（Switzerland）
• Sinclair Pharma（UK）
• Allergan Aesthetics（a subsidiary of AbbVie）（US）
• Hugel, Inc.（South Korea）
• Sientra, Inc.（US）
• Revance Therapeutics, Inc.（US）
• Evolus, Inc.（US）
• Medytox Inc.（South Korea）
• Hugel, Inc.（South Korea）
• AptarGroup, Inc.（US）
• Ipsen SA（France）
• Galderma SA（Switzerland）
• Revanesse（Canada）
• Merz North America（US）
• Suneva Medical, Inc.（US）
• Aesthetic Medical International Holdings Group（China）
• Neauvia（Switzerland）

Global Facial Injectables Market size was valued at USD 10.1 billion in 2022 and is poised to grow from USD 11.31 billion in 2023 to USD 28.01 billion by 2031, growing at a CAGR of 12.00% during the forecast period (2024-2031).

The global facial injectables market is set for substantial growth in the coming years, driven by an increasing demand for facial aesthetic enhancements. This sector encompasses the production, distribution, and application of injectable substances specifically designed for aesthetic treatments, primarily focusing on anti-aging solutions that reduce wrinkles, restore facial volume, and improve overall skin appearance. The market primarily revolves around two key methodologies: botulinum toxin injections and dermal fillers, both of which enhance skin glow and moisture retention, leading to improved texture. As consumer interest in facial cosmetics rises, coupled with a surge in disposable income among younger demographics, spending on beauty and cosmetic products is expected to see a positive uptick. Notably, the U.S. facial injectables market is anticipated to achieve a sustainable compound annual growth rate (CAGR) in the upcoming forecast period, reflecting the broader trend of increased consumer engagement with aesthetic treatments. The growing societal emphasis on appearance and self-care is further positioning the facial injectables market for continued expansion, making it a key area for investment and innovation within the beauty and wellness industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Facial Injectables market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Facial Injectables Market Segmental Analysis

Global Facial Injectables Market is segmented by Product, Application, End-use and region. Based on component, the market is segmented into Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-lactic Acid (PLLA), and Others. Based on Application, the market is segmented into Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, and Others. Based on End-use, the market is segmented into MedSpas, Dermatology Clinics, Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Facial Injectables Market

The Global Facial Injectables market is poised for substantial growth, driven by the escalating consumer demand for non-invasive aesthetic solutions, particularly among the Millennial demographic, who increasingly favor facial injectables to address skin damage caused by environmental factors and lifestyle choices. With products like collagen fibers, hyaluronic acid fillers, and synthetic injectables, consumers are attracted to the dual benefits of hydration and UV protection, alongside minimal side effects. Additionally, rising disposable incomes and advancements in technology, which enhance safety by reducing infection risks and procedure costs, are further fueling the market's expansion during the forecast period.

Restraints in the Global Facial Injectables Market

The Global Facial Injectables market faces several market restraints that limit its expansion. Stringent regulatory requirements and limitations concerning product approval create barriers to entry and complicate the commercialization of new solutions. Additionally, skin-related side effects such as rashes and redness discourage potential consumers from seeking these treatments, especially as safety concerns grow. High costs associated with fillers can also deter patients from opting for facial injectables, while the lack of insurance coverage for aesthetic procedures further exacerbates the issue, restricting market growth. Together, these factors create a challenging environment for the advancement of the global facial injectables industry.

Market Trends of the Global Facial Injectables Market

The Global Facial Injectables market is witnessing a significant trend fueled by the rising acceptance of these cosmetic treatments among the male population. As more men seek anti-aging solutions, the adoption of dermal fillers and botulinum toxin is on the rise, reflecting a shift in societal norms around male aesthetics. Young males, in particular, are increasingly inclined towards tissue fillers for rejuvenation purposes, further driving this trend. Additionally, hyaluronic acid fillers are gaining traction due to their efficacy in anti-aging treatments, propelling market growth. This evolving landscape indicates a broader demographic embracing facial injectables, expanding the market's potential.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Facial Injectables Market by Product

• Market Overview
• Collagen & PMMA Microspheres
• Hyaluronic Acid (HA)
• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Poly-L-lactic Acid (PLLA)
• Others

Facial Injectables Market by Application

• Market Overview
• Facial Line Correction
• Lip Augmentation
• Face Lift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Others

Facial Injectables Market by End-use

• Market Overview
• MedSpas
• Dermatology Clinics
• Hospitals

Facial Injectables Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Ispen (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbvie (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medytox Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz GmbH and Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinclair Pharma (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan Aesthetics (a subsidiary of AbbVie) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hugel, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sientra, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evolus, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medytox Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hugel, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ipsen S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revanesse (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz North America (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suneva Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesthetic Medical International Holdings Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neauvia (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments